Skip to main content
See every side of every news story
Published • loading... • Updated

Company Linked to Trump Sons Lands Ebola Contracts

The awards include $20 million for outbreak response and $18.8 million for Ebola screening, despite XpresTest’s limited experience abroad.

  • President Donald Trump's administration awarded biosecurity firm XpresTest nearly $40 million to screen for Ebola and other infectious diseases, months after a firm linked to Donald Jr. and Eric Trump invested in its parent company, XWELL.
  • American Ventures, a fund launched by Dominari Holdings, invested about $30 million in XWELL after hiring Donald Jr. and Eric Trump as advisers and granting them a stake of more than 10%.
  • XpresTest has never worked with Ebola or provided biosecurity services abroad, yet CEO Ezra Ernst acknowledged that international work is "a new thing for us" and expressed uncertainty about completing the response.
  • In July, XWELL announced plans to sell XpresTest to a private spa company, with Ernst saying the government contracts played a role in the $13 million sale price and will follow the subsidiary to its new owner.
  • These biosecurity awards join broader questions about Trump family financial activities during his second term, with the House Oversight Committee, now led by Democrats, expected to prioritize investigating such government ties in the coming months.
Insights by Ground AI

11 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 89% of the sources lean Left
89% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ProPublica broke the news in New York, United States on Monday, November 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal